132.94
price up icon1.25%   1.64
pre-market  Pre-market:  133.23   0.29   +0.22%
loading
Abbott Laboratories stock is traded at $132.94, with a volume of 5.59M. It is up +1.25% in the last 24 hours and up +3.17% over the past month. Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
See More
Previous Close:
$131.30
Open:
$131.85
24h Volume:
5.59M
Relative Volume:
0.80
Market Cap:
$231.29B
Revenue:
$42.34B
Net Income/Loss:
$13.50B
P/E Ratio:
17.24
EPS:
7.71
Net Cash Flow:
$6.66B
1W Performance:
-1.67%
1M Performance:
+3.17%
6M Performance:
+11.76%
1Y Performance:
+27.89%
1-Day Range:
Value
$131.53
$133.84
1-Week Range:
Value
$130.43
$136.17
52-Week Range:
Value
$99.71
$140.84

Abbott Laboratories Stock (ABT) Company Profile

Name
Name
Abbott Laboratories
Name
Phone
(224) 667-6100
Name
Address
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
Employee
114,000
Name
Twitter
@AbbottNews
Name
Next Earnings Date
2025-04-16
Name
Latest SEC Filings
Name
ABT's Discussions on Twitter

Compare ABT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
ABT
Abbott Laboratories
132.94 235.23B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
106.17 157.62B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
383.78 148.87B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
81.18 110.72B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
76.22 45.66B 5.54B 4.18B 623.10M 7.00

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-08-24 Initiated Oppenheimer Outperform
Sep-19-24 Initiated Piper Sandler Overweight
Jul-30-24 Downgrade Edward Jones Buy → Hold
May-30-24 Initiated Goldman Buy
Jul-21-23 Upgrade Wolfe Research Underperform → Peer Perform
May-30-23 Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-20-23 Reiterated Barclays Overweight
Apr-20-23 Reiterated Bernstein Outperform
Apr-20-23 Reiterated JP Morgan Overweight
Apr-20-23 Reiterated Raymond James Outperform
Apr-20-23 Reiterated UBS Buy
Apr-20-23 Reiterated Wolfe Research Underperform
Mar-29-23 Initiated UBS Buy
Oct-26-22 Initiated Mizuho Neutral
Oct-18-22 Initiated Barclays Overweight
Oct-12-22 Initiated Jefferies Hold
Jul-06-22 Initiated Wolfe Research Underperform
Mar-02-22 Resumed BofA Securities Buy
Jan-27-22 Reiterated Credit Suisse Outperform
Jan-27-22 Reiterated Morgan Stanley Overweight
Jan-27-22 Reiterated Raymond James Outperform
Jan-27-22 Reiterated UBS Buy
Dec-10-21 Initiated RBC Capital Mkts Outperform
Oct-27-21 Upgrade Atlantic Equities Neutral → Overweight
Oct-14-21 Initiated Redburn Neutral
May-25-21 Initiated Barclays Overweight
Apr-15-21 Initiated Atlantic Equities Neutral
Jan-28-21 Upgrade BTIG Research Neutral → Buy
Sep-11-20 Initiated Wolfe Research Outperform
Jun-01-20 Downgrade Goldman Neutral → Sell
Mar-05-20 Initiated Citigroup Buy
Feb-13-20 Initiated Goldman Neutral
Feb-06-20 Resumed BTIG Research Neutral
Jan-02-20 Downgrade Guggenheim Buy → Neutral
Jun-13-19 Reiterated BofA/Merrill Buy
Feb-07-19 Reiterated BofA/Merrill Buy
Jan-02-19 Downgrade Citigroup Neutral → Sell
Nov-30-18 Upgrade Goldman Neutral → Buy
Oct-16-18 Initiated Barclays Overweight
Jun-27-18 Initiated Bernstein Outperform
Jan-30-18 Reiterated Citigroup Neutral
Jan-25-18 Reiterated Stifel Buy
Jan-25-18 Upgrade William Blair Mkt Perform → Outperform
Jan-03-18 Initiated Evercore ISI Outperform
Jan-02-18 Upgrade JP Morgan Neutral → Overweight
Jan-02-18 Upgrade Morgan Stanley Equal-Weight → Overweight
Oct-19-17 Reiterated RBC Capital Mkts Outperform
Oct-19-17 Reiterated Stifel Buy
View All

Abbott Laboratories Stock (ABT) Latest News

pulisher
05:51 AM

The Zacks Analyst Blog Highlights Coca-Cola, Abbott Laboratories and AT&T - TradingView

05:51 AM
pulisher
03:18 AM

Cardiac Implants Market Is Booming Worldwide | Abbott - openPR.com

03:18 AM
pulisher
May 27, 2025

Abbott Gains FDA Approval for Tendyne™, Strengthening Its Minimally Invasive Heart Portfolio - Yahoo

May 27, 2025
pulisher
May 27, 2025

Abbott Stakes Claim in TMVR Market with New FDA Approval - Medical Device and Diagnostic industry

May 27, 2025
pulisher
May 27, 2025

Top Stock Reports for Coca-Cola, Abbott & AT&T - TradingView

May 27, 2025
pulisher
May 27, 2025

Abbott Laboratories’ SWOT analysis: diversified portfolio bolsters stock amid challenges - Investing.com

May 27, 2025
pulisher
May 27, 2025

FDA approves self-expanding Tendyne TMVR device from Abbott - Cardiovascular Business

May 27, 2025
pulisher
May 27, 2025

Abbott wins approval for open-heart surgery-free valve replacement - Crain's Chicago Business

May 27, 2025
pulisher
May 27, 2025

Biochips Market Poised Boom | Abbott Laboratories, Agilent Technologies, Inc., PerkinElmer, Inc - openPR.com

May 27, 2025
pulisher
May 27, 2025

Abbott Labs (ABT) Receives FDA Approval for Tendyne Heart Valve System - GuruFocus

May 27, 2025
pulisher
May 27, 2025

FDA approves Abbott mitral valve replacement device that doesn't require open-heart surgery - MassDevice

May 27, 2025
pulisher
May 27, 2025

Abbott gets FDA nod for Tendyne valve for mitral valve disease - Seeking Alpha

May 27, 2025
pulisher
May 27, 2025

Abbott Says Tendyne Transcatheter Mitral Valve Replacement System Receives FDA Approval - marketscreener.com

May 27, 2025
pulisher
May 27, 2025

Abbott’s Tendyne valve gets FDA nod for mitral replacement By Investing.com - Investing.com Canada

May 27, 2025
pulisher
May 27, 2025

Abbott (ABT) Receives FDA Approval for Tendyne Heart Valve System | ABT Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Abbott’s Tendyne valve gets FDA nod for mitral replacement - Investing.com

May 27, 2025
pulisher
May 27, 2025

Oman Dietary Supplements Market Forecast Report to 2030, with Profiles of Nature's Way, Amway, Pfizer Gulf, Abbott Laboratories, Herbalife Nutrition, Nestle & Oman Pharmaceutical Products - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

A Look At The Intrinsic Value Of Abbott Laboratories (NYSE:ABT) - Yahoo Finance

May 27, 2025
pulisher
May 27, 2025

Abbott Laboratories: Why Wall Street's Skepticism Misses The Real Story - Seeking Alpha

May 27, 2025
pulisher
May 24, 2025

If You Invested $10K In Abbott Laboratories Stock 10 Years Ago, How Much Would You Have Now? - Yahoo Finance

May 24, 2025
pulisher
May 24, 2025

Abbott Laboratories (ABT) Benefitted From Better Execution - MSN

May 24, 2025
pulisher
May 24, 2025

STHS unveils groundbreaking lab upgrade from Abbott at St. Tammany Parish Hospital - an17.com

May 24, 2025
pulisher
May 23, 2025

Abbott Laboratories (NYSE:ABT) Collaborates On Advanced Diabetes Management With Glucose-Ketone Sensor Integration - simplywall.st

May 23, 2025
pulisher
May 23, 2025

Abbott Laboratories (ABT) was up 16% in Q1 - Insider Monkey

May 23, 2025
pulisher
May 23, 2025

Was Jim Cramer Right About Abbott Laboratories (ABT)? - MSN

May 23, 2025
pulisher
May 23, 2025

2 Dividend Stocks to Buy With $500 and Hold Forever - The Motley Fool

May 23, 2025
pulisher
May 23, 2025

Blood Glucose Monitoring (BGM) Devices Market Report 2025: Hospitals Lead in Blood Glucose Monitoring Device Usage, Home Care Grows Fastest - GlobeNewswire Inc.

May 23, 2025
pulisher
May 22, 2025

From Acquisition to Advantage: Abbott's Growth in Heart Care - Yahoo Finance

May 22, 2025
pulisher
May 22, 2025

Abbott vs. Medtronic: Which Dividend-Paying MedTech Stock is Better? - Yahoo Finance

May 22, 2025
pulisher
May 22, 2025

Researchers question reliability of Abbott’s rapid malaria tests - Science | AAAS

May 22, 2025
pulisher
May 21, 2025

Senseonics Holdings, Inc. Secures $57.5 Million in Public Offering and $20.3 Million from Private Placement with Abbott Laboratories - Nasdaq

May 21, 2025
pulisher
May 21, 2025

Senseonics Secures Massive $77.8M Funding Boost as Abbott Backs Next-Gen Diabetes Monitor Launch - Stock Titan

May 21, 2025
pulisher
May 21, 2025

The Growth Of Medical Devices Needs To Continue In Order To Invest In Abbott (NYSE:ABT) - Seeking Alpha

May 21, 2025
pulisher
May 21, 2025

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

May 21, 2025
pulisher
May 21, 2025

Do Abbott Laboratories' (NYSE:ABT) Earnings Warrant Your Attention? - Yahoo Finance

May 21, 2025
pulisher
May 21, 2025

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Alcon (ALC) - The Globe and Mail

May 21, 2025
pulisher
May 20, 2025

Solid Results Boosted Abbott Laboratories’ (ABT) Performance in Q1 - Insider Monkey

May 20, 2025
pulisher
May 20, 2025

Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views? - Nasdaq

May 20, 2025
pulisher
May 20, 2025

Biotechnology Market Set to Witness Significant Growth by 2025-2032 | Abbott Laboratories, Amgen Inc., - EIN News

May 20, 2025
pulisher
May 19, 2025

United States Generic Drugs Market Forecast and Company Analysis Report 2025-2033 Featuring Teva Pharma, Aurobindo Pharma, Sun Pharma, Abbott Laboratories, Lupin Pharma, Viatris, Sandoz, Dr. Reddy'sResearchAndMarkets.com - FinancialContent

May 19, 2025
pulisher
May 19, 2025

Abbott Laboratories (ABT)’s Libre Linked to Fewer Heart Hospitalizations in Diabetes - MSN

May 19, 2025
pulisher
May 19, 2025

Abbott Reveals Positive Outcome From REFLECT Studies, Stock Climbs - Zacks Investment Research

May 19, 2025
pulisher
May 19, 2025

Abbott and Epic Collaborate to Streamline Glucose Data Access for Providers - The Healthcare Technology Report.

May 19, 2025
pulisher
May 19, 2025

Abbott Laboratories' segment revenues from 2017 to 2024 - Statista

May 19, 2025
pulisher
May 17, 2025

3 Magnificent Stocks That Are Passive Income Machines - The Globe and Mail

May 17, 2025
pulisher
May 16, 2025

Abbott (ABT) Up 1.8% Since Last Earnings Report: Can It Continue? - Yahoo Finance

May 16, 2025
pulisher
May 16, 2025

North America Weight Management Products Market Report 2025-2033 Featuring Abbott, Nestle, Herbalife, Woodbolt, Premier Nutrition, Iovate, Kellogg, Ultimate Nutrition, Simply Good Foods, GlanbiaResearchAndMarkets.com - FinancialContent

May 16, 2025
pulisher
May 16, 2025

United States Nutraceuticals Market Forecast Report 2025-2033 Featuring PepsiCo, General Mills, Nestle, Kellogg, Herbalife, Danone, Now Foods, Alticor, Red Bull, and Abbott Laboratories - GlobeNewswire

May 16, 2025
pulisher
May 16, 2025

Europe Meal Replacement Products Market Forecast Report 2025-2033 Featuring Abbott Laboratories, Amway, Herbalife, The Simply Good Foods Co, Nestle, Peeroton, Huel, THG, USN, and Abnormal - Yahoo

May 16, 2025
pulisher
May 16, 2025

Abbott India rises after Q4 PAT jumps 28% YoY to Rs 367 cr; declares dividend of Rs 475 /sh - Business Standard

May 16, 2025
pulisher
May 15, 2025

Abbott studies show CGM users have fewer hospitalizations - BioWorld MedTech

May 15, 2025

Abbott Laboratories Stock (ABT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_devices BSX
$106.17
price up icon 1.60%
medical_devices SYK
$383.78
price up icon 1.90%
medical_devices MDT
$81.18
price up icon 0.62%
medical_devices EW
$76.22
price up icon 1.64%
$85.33
price up icon 0.97%
Cap:     |  Volume (24h):